Cargando…
Ninety-Day Oral Toxicity Assessment of an Alternative Biopolymer for Controlled Release Drug Delivery Systems Obtained from Cassava Starch Acetate
The large consumption of biodegradable films from cassava starch acetate (FCSA) as ingredients in food and pharmaceutical products requires the assessment of the possible toxicity of these products. The aim of this study was to investigate the toxicity of biodegradable film from cassava starch aceta...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584237/ https://www.ncbi.nlm.nih.gov/pubmed/26451154 http://dx.doi.org/10.1155/2015/390416 |
_version_ | 1782391955706085376 |
---|---|
author | Jesus, Douglas Rossi Barbosa, Lorena Neris Prando, Thiago Bruno Lima Martins, Leonardo Franco Gasparotto, Francielli Guedes, Karla Moraes Rocha Dragunski, Douglas Cardoso Lourenço, Emerson Luiz Botelho Dalsenter, Paulo Roberto Gasparotto Junior, Arquimedes |
author_facet | Jesus, Douglas Rossi Barbosa, Lorena Neris Prando, Thiago Bruno Lima Martins, Leonardo Franco Gasparotto, Francielli Guedes, Karla Moraes Rocha Dragunski, Douglas Cardoso Lourenço, Emerson Luiz Botelho Dalsenter, Paulo Roberto Gasparotto Junior, Arquimedes |
author_sort | Jesus, Douglas Rossi |
collection | PubMed |
description | The large consumption of biodegradable films from cassava starch acetate (FCSA) as ingredients in food and pharmaceutical products requires the assessment of the possible toxicity of these products. The aim of this study was to investigate the toxicity of biodegradable film from cassava starch acetate after oral exposure of Wistar rats for 90 days. The amount of food consumed and the body weight were weekly monitored. Blood and urine samples were obtained for the assessment of serum parameters and renal function. Histopathological analyses in target organs were also performed. No evidence of clinical toxicity in hematological, biochemical, or renal parameters in the FCSA-treated animals was found. In addition, relative organ weight and histopathological evaluations did not differ between groups treated with FCSA and control. Data obtained suggest that the subchronic exposure to FCSA does not cause obvious signs of toxicity in Wistar rats, indicating possible safety of this biofilm. |
format | Online Article Text |
id | pubmed-4584237 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-45842372015-10-08 Ninety-Day Oral Toxicity Assessment of an Alternative Biopolymer for Controlled Release Drug Delivery Systems Obtained from Cassava Starch Acetate Jesus, Douglas Rossi Barbosa, Lorena Neris Prando, Thiago Bruno Lima Martins, Leonardo Franco Gasparotto, Francielli Guedes, Karla Moraes Rocha Dragunski, Douglas Cardoso Lourenço, Emerson Luiz Botelho Dalsenter, Paulo Roberto Gasparotto Junior, Arquimedes Evid Based Complement Alternat Med Research Article The large consumption of biodegradable films from cassava starch acetate (FCSA) as ingredients in food and pharmaceutical products requires the assessment of the possible toxicity of these products. The aim of this study was to investigate the toxicity of biodegradable film from cassava starch acetate after oral exposure of Wistar rats for 90 days. The amount of food consumed and the body weight were weekly monitored. Blood and urine samples were obtained for the assessment of serum parameters and renal function. Histopathological analyses in target organs were also performed. No evidence of clinical toxicity in hematological, biochemical, or renal parameters in the FCSA-treated animals was found. In addition, relative organ weight and histopathological evaluations did not differ between groups treated with FCSA and control. Data obtained suggest that the subchronic exposure to FCSA does not cause obvious signs of toxicity in Wistar rats, indicating possible safety of this biofilm. Hindawi Publishing Corporation 2015 2015-09-14 /pmc/articles/PMC4584237/ /pubmed/26451154 http://dx.doi.org/10.1155/2015/390416 Text en Copyright © 2015 Douglas Rossi Jesus et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Jesus, Douglas Rossi Barbosa, Lorena Neris Prando, Thiago Bruno Lima Martins, Leonardo Franco Gasparotto, Francielli Guedes, Karla Moraes Rocha Dragunski, Douglas Cardoso Lourenço, Emerson Luiz Botelho Dalsenter, Paulo Roberto Gasparotto Junior, Arquimedes Ninety-Day Oral Toxicity Assessment of an Alternative Biopolymer for Controlled Release Drug Delivery Systems Obtained from Cassava Starch Acetate |
title | Ninety-Day Oral Toxicity Assessment of an Alternative Biopolymer for Controlled Release Drug Delivery Systems Obtained from Cassava Starch Acetate |
title_full | Ninety-Day Oral Toxicity Assessment of an Alternative Biopolymer for Controlled Release Drug Delivery Systems Obtained from Cassava Starch Acetate |
title_fullStr | Ninety-Day Oral Toxicity Assessment of an Alternative Biopolymer for Controlled Release Drug Delivery Systems Obtained from Cassava Starch Acetate |
title_full_unstemmed | Ninety-Day Oral Toxicity Assessment of an Alternative Biopolymer for Controlled Release Drug Delivery Systems Obtained from Cassava Starch Acetate |
title_short | Ninety-Day Oral Toxicity Assessment of an Alternative Biopolymer for Controlled Release Drug Delivery Systems Obtained from Cassava Starch Acetate |
title_sort | ninety-day oral toxicity assessment of an alternative biopolymer for controlled release drug delivery systems obtained from cassava starch acetate |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584237/ https://www.ncbi.nlm.nih.gov/pubmed/26451154 http://dx.doi.org/10.1155/2015/390416 |
work_keys_str_mv | AT jesusdouglasrossi ninetydayoraltoxicityassessmentofanalternativebiopolymerforcontrolledreleasedrugdeliverysystemsobtainedfromcassavastarchacetate AT barbosalorenaneris ninetydayoraltoxicityassessmentofanalternativebiopolymerforcontrolledreleasedrugdeliverysystemsobtainedfromcassavastarchacetate AT prandothiagobrunolima ninetydayoraltoxicityassessmentofanalternativebiopolymerforcontrolledreleasedrugdeliverysystemsobtainedfromcassavastarchacetate AT martinsleonardofranco ninetydayoraltoxicityassessmentofanalternativebiopolymerforcontrolledreleasedrugdeliverysystemsobtainedfromcassavastarchacetate AT gasparottofrancielli ninetydayoraltoxicityassessmentofanalternativebiopolymerforcontrolledreleasedrugdeliverysystemsobtainedfromcassavastarchacetate AT guedeskarlamoraesrocha ninetydayoraltoxicityassessmentofanalternativebiopolymerforcontrolledreleasedrugdeliverysystemsobtainedfromcassavastarchacetate AT dragunskidouglascardoso ninetydayoraltoxicityassessmentofanalternativebiopolymerforcontrolledreleasedrugdeliverysystemsobtainedfromcassavastarchacetate AT lourencoemersonluizbotelho ninetydayoraltoxicityassessmentofanalternativebiopolymerforcontrolledreleasedrugdeliverysystemsobtainedfromcassavastarchacetate AT dalsenterpauloroberto ninetydayoraltoxicityassessmentofanalternativebiopolymerforcontrolledreleasedrugdeliverysystemsobtainedfromcassavastarchacetate AT gasparottojuniorarquimedes ninetydayoraltoxicityassessmentofanalternativebiopolymerforcontrolledreleasedrugdeliverysystemsobtainedfromcassavastarchacetate |